The Role of CAR NK Cells: Competition or Compliment to CAR T-Cell Therapy?
June 13th 2021
New studies into chimeric antigen receptor (CAR)–engineered natural killer (NK) cells has shown promising results, explained Ulrike Köhl, PhD, MD, professor of immune oncology and director of the Institute for Clinical Immunology at the University of Leipzig in Germany.